Related Experiment Video

Updated: Dec 29, 2025

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

2.8K

Pembrolizumab treatment for progressive multifocal leukoencephalopathy in a patient with Human Immunodeficiency Virus

Marta Mozo Ruiz1, Noemí Rosado Barrasa2, Daniel Tena Gómez3

  • 1Servicio de Medicina Interna, Hospital Universitario de Guadalajara, Guadalajara, España.

Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)
|February 2, 2020
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models
09:54

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models

Published on: December 3, 2019

10.5K
Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
11:08

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

1.6K

Related Experiment Videos

Last Updated: Dec 29, 2025

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

2.8K
Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models
09:54

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models

Published on: December 3, 2019

10.5K
Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
11:08

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

1.6K

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

1.8K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.8K

Articles linked to this work by shared authors, journal, and citation graph.

Effect of Non-nucleoside Resistance-Associated Mutations on the Effectiveness of Long-Acting Cabotegravir + Rilpivirine Therapy: Insights From the Real-World RELATIVITY Cohort.

Open forum infectious diseases·2026

Genotyping not required for sustained effectiveness of long-acting cabotegravir plus rilpivirine: evidence from the RELATIVITY cohort.

AIDS (London, England)·2025

Changes in the epidemiology of hepatitis A: Clinical and preventive implications.

Gastroenterologia y hepatologia·2022

High Seroprevalence Against SARS-CoV-2 Among Faculty of Medicine and Health Sciences Personnel and Students of the University of Alcalá, Spain: Contributing Factors.

International journal of general medicine·2021

Comparison of Three Classification Criteria Sets for Systemic Lupus Erythematosus: A Study Looking at Links to Outcome and Mortality.

Arthritis care & research·2019

Why do some patients with systemic lupus erythematosus fail to respond to B-cell depletion using rituximab?

Clinical and experimental rheumatology·2019

Severe ocular mpox in an immunocompetent patient.

Enfermedades infecciosas y microbiologia clinica (English ed.)·2026

Video supported treatment among vulnerable populations with tuberculosis: Data from prospective multi-centre single-arm cohort study in Catalonia, Spain.

Enfermedades infecciosas y microbiologia clinica (English ed.)·2026

Comparison of two chemiluminescence assays for the detection of Helicobacter pylori antigen in stool samples.

Enfermedades infecciosas y microbiologia clinica (English ed.)·2026

Factors associated with high-flow therapy failure in COVID-19-related acute hypoxemic respiratory failure: A prospective single-centre cohort study.

Enfermedades infecciosas y microbiologia clinica (English ed.)·2026

Characterization of herpes zoster cases and epidemiological trends in the Community of Madrid before and after the vaccine introduction in older adults: 2016-2025.

Enfermedades infecciosas y microbiologia clinica (English ed.)·2026

Disseminated histoplasmosis with gastrointestinal involvement in a patient with HIV: Case report and systematic review of the literature.

Enfermedades infecciosas y microbiologia clinica (English ed.)·2026

An IL-21R STAT hypomorph circumvents functional redundancy in germinal centre responses.

eLife·2026

A narrative review of stem cell-based therapy for fibrosing interstitial lung diseases: clinical evidence and translational perspectives.

Frontiers in pharmacology·2026

Clinicopathologic characteristics and diagnostic value of PD-L1 in immune checkpoint inhibitor-related liver injury: a single-center retrospective study.

Frontiers in oncology·2026

Kidney biopsy in the diagnosis of immunoglobulin A nephropathy.

Frontiers in medicine·2026

The Largest Cohort Study of Intravenous Leiomyomatosis Reveals HMGA2 and Collagen Gene Alterations as Cooperative Drivers.

The American journal of surgical pathology·2026

An interferonopathy associated with a monoallelic variant in TRIM28.

Pediatric rheumatology online journal·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us